๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

RHabdomyosarcoma: Response with chemotherapy prior to radiation in patients with gross residual disease

โœ Scribed by Melvin Tefft; Carlos H. Fernandez; Thomas E. Moon

Publisher
John Wiley and Sons
Year
1977
Tongue
English
Weight
433 KB
Volume
39
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Extreme drug resistance assay and respon
Extreme drug resistance assay and response to chemotherapy in patients with primary peritoneal carcinoma
โœ Eltabbakh, Gamal H. ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 1 views

## Background and Objectives: The extreme drug resistance (EDR) assay is an in vitro chemoresistance assay performed on tumor samples grown in culture and is claimed to predict drugs unlikely to produce response. Its clinical value in patients with epithelial ovarian cancer (EOC) has recently been

Predicting response to adjuvant and radi
Predicting response to adjuvant and radiation therapy in patients with early stage breast carcinoma
โœ Harry B. Burke; Albert Hoang; J. Dirk Iglehart; Jeffrey R. Marks ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 154 KB ๐Ÿ‘ 2 views

## Background: Screening and surveillance is increasing the detection of early stage breast carcinoma. the ability to predict accurately the response to adjuvant therapy (chemotherapy or tamoxifen therapy) or postlumpectomy radiation therapy in these patients can be vital to their survival, because